Status:

ACTIVE_NOT_RECRUITING

Prevention of NAFLD in Hispanic Children

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Non-Alcoholic Fatty Liver Disease

Eligibility:

All Genders

6-9 years

Phase:

NA

Brief Summary

This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.

Detailed Description

The number of children experiencing obesity and the chronic diseases associated with it have risen dramatically in recent decades. This includes non-alcoholic fatty liver disease (NAFLD). NAFLD is an ...

Eligibility Criteria

Inclusion

  • At least one parent or the child self-identifies as Hispanic or Latino.
  • BMI ≥ 50th percentile for age and sex.
  • Age ≥ 6 years and ≤ 9 years
  • Tanner stage 1 by self and/or parental report
  • Normal ALT on screening labs (≤23 IU for girls, ≤26 IU for boys)
  • Written informed consent from parent or legal guardian, assent from child

Exclusion

  • Known diagnosis of chronic liver disease other than NAFLD and "fatty liver"
  • History of significant depression
  • Implanted metal or other implant (braces ok), or claustrophobia or other reason that contraindicates MRI
  • Type 2 diabetes (Hemoglobin A1c \> 6.4% on screening labs or chronic diagnosis)
  • Plans to move within the next 12 months
  • Current or previous participation in a weight loss program or obesity treatment program or clinic
  • Cancer or history of cancer
  • Recipient of a liver transplant
  • Chronic use (in the last year) of medications known to cause NAFLD or fatty liver (TPN, amiodarone, chronic oral steroids, etc.)
  • Intellectual disability or major psychiatric disorder limiting informed assent
  • At risk for eating disorder by screening instrument
  • Participants who are currently enrolled in a clinical trial or have received an investigational product within the last 60 days
  • Participants who are not able or willing to comply with the diet protocol or have any other condition or circumstance that would impede compliance or hinder completion of the study in the opinion of the investigator
  • Children who spend more than 1 night per week consistently in another household

Key Trial Info

Start Date :

April 6 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2027

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT05292352

Start Date

April 6 2022

End Date

January 31 2027

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory University

Atlanta, Georgia, United States, 30329

Prevention of NAFLD in Hispanic Children | DecenTrialz